The leukotrienes (LTs) constitute a family of 5-lipoxygenase products of arachidonic acid metabolism which have been shown to effect peripheral airway smooth muscle constriction, increased vascular permeability, and granulocyte chemotaxis at nanomolar concentrations, such that their potencies for these pro-inflammatory effects are, in general, two to three orders of magnitude greater than those of other known mediators. Depending upon the organ system in which they are generated, these compounds are thus of potential relevance to a wide spectrum of inflammatory events including asthma, various forms of arthritis, and pathological vascular events involving inflammation in either an initiating or a potentiating capacity. We intend to explore a number of aspects of the biology of these compounds including cellular origins; the mechanisms of cell activation to generate LTs; isolation and characterization of specific enzymes in the LT biosynthesis pathway; biological effects on contractile, vascular and chemotactic assay systems; and isolation and identification of their receptors, with characterization of the chemical basis for interaction of LT and receptor. Additionally, we intend to pursue the discovery of inhibitors of both the biosynthetic enzymes and of the functional response to the LTs. The accomplishment of this project depends upon the unique capabilities of each contributing group: development of anti-leukotriene radioimmunoassays, including production of monoclonal antibodies, enzyme purification, receptor identification and characterization, and functional evaluation of inhibitors and antagonists at Harvard Medical School; cell culture and immunopharmacology of cell activation with product identification by radioimmunoassays at Brandeis University; and the entire chemical initiative, including synthesis of natural leukotrienes, design and synthesis of LT analog compounds at LT-carrier protein immunogens, development of affinity reagents, and the design and synthesis of enzyme inhibitors and functional antagonists at the Department of Chemistry, Harvard University.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022563-02
Application #
3133813
Study Section
(SSS)
Project Start
1985-01-01
Project End
1987-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Tobias, P S; Ulevitch, R J (1993) Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 187:227-32
Lam, B K; Xu, K; Atkins, M B et al. (1992) Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4. Proc Natl Acad Sci U S A 89:11598-602
Penrose, J F; Gagnon, L; Goppelt-Struebe, M et al. (1992) Purification of human leukotriene C4 synthase. Proc Natl Acad Sci U S A 89:11603-6
Her, E; Frazer, J; Austen, K F et al. (1991) Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 88:1982-7
Owen Jr, W F; Petersen, J; Austen, K F (1991) Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP. J Clin Invest 87:1958-63
Lam, B K; Gagnon, L; Austen, K F et al. (1990) The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes. J Biol Chem 265:13438-41
Soberman, R J (1990) Cytochrome P-450LTB and inactivation of leukotriene B4. Methods Enzymol 187:319-24
Soberman, R J (1990) Purification and properties of leukotriene C4 synthase from guinea pig lung microsomes. Methods Enzymol 187:335-7
Lewis, R A; Austen, K F; Soberman, R J (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323:645-55
Ling, C J; Owen Jr, W F; Austen, K F (1990) Human fibroblasts maintain the viability and augment the functional response of human neutrophils in culture. J Clin Invest 85:601-4

Showing the most recent 10 out of 45 publications